Dengue Academy is intended for an international audience of healthcare professionals outside of the US and UK.
This website has been initiated and developed by Takeda

© Copyright 2022 Takeda Pharmaceutical Company Limited. All rights reserved.
Takeda and the Takeda Logo are registered trademarks of Takeda Pharmaceutical Company Limited.
VV-MEDMAT-55340, Date of preparation: November 2021

Severe Dengue

Dengue disease awareness

ISID

39 minutes
Coagulation abnormalities in Dengue fever infection: A systematic review and meta-analysis

Takeda

2 minutes
A fatal case report of antibody-dependent enhancement of dengue virus type 1 following remote Zika virus infection

Takeda

2 minutes
Dengue serotypes

Takeda

4 minutes
Effects of dengue

Takeda

7 minutes
Dengue and Covid-19

Takeda

7 minutes
NS1 and its potential association with severe dengue

Takeda

3 minutes
Managing the severely ill dengue patients – Adult and Paediatric Intensivists

ADVA

92 minutes
Similarities and differences between 'cytokine storms’ in acute dengue and COVID-19

Takeda

2 minutes
Dengue and post-infection fatigue: findings from a prospective cohort study

Takeda

2 minutes

Dengue Academy is intended for an international audience of healthcare professionals outside of the US and UK.
This website has been initiated and developed by Takeda